Pharmaceuticals, Biotechnology and Life Sciences
WOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–$ABAHF #AbacusHealthProducts–Abacus Health Products, Inc. (CSE:ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that it…
Agreement with Biogen covers Samsung Bioepis’ biosimilar candidates in pre-clinical and clinical development, which reference two widely-used biologic medicines in…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB :ASPCF) will announce its third quarter 2019 financial and operating results on Thursday, November…
Arix Bioscience said Wednesday that its portfolio company Artios Pharma Ltd, has entered in-licensing agreement of a small-molecule ATR inhibitor programme from The University of Texas MD Anderson Cancer Center and ShangPharma.
— Third-Quarter 2019 Net Sales of $335.5 Million Increased 3 Percent; Third-Quarter 2019 GAAP Net Income of $18.2 Million; Adjusted…
LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will host a conference call and webcast event…
DUBLIN & BURLINGAME, Calif.–(BUSINESS WIRE)–ALX Oncology, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, will present…
Backing will propel PAI’s market leadership position and help capitalize on growth opportunities NEW YORK–(BUSINESS WIRE)–Enhanced Healthcare Partners (“EHP”), a…
Positive interim results announced from Phase 1 CMV vaccine (mRNA-1647) study Positive interim results announced from Phase 1 mRNA encoding…
BETHESDA, Md.–(BUSINESS WIRE)–#AD–India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended September 30, 2019,…